Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Statement on December 2025 ACIP Meeting
WASHINGTON, D.C. – Phyllis Arthur, Executive Vice President and Head of Health Policy and Programs of the Biotechnology Innovation Organization (BIO) released the following statement on the December 2025 ACIP meeting.“For decades, the CDC’s Advisory…
Learn more
BIO Statement on the Retirement of Richard Pazdur…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on reports of the retirement of Richard Pazdur from the US FDA.“Dr. Pazdur has dedicated decades of his career…
Learn more
BIO Statement on House Passage of Mikaela Naylon…
WASHINGTON, D.C. – The Biotechnology Innovation Organization (BIO) released the following statement on today’s passage of the Mikaela Naylon Give Kids a Chance Act in the House of Representatives.“The unanimous House passage of the Mikaela Naylon…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Applauds Senate Introduction of Renewable Chemicals Tax Credit
October 19, 2017
BIO thanks Sen. Debbie Stabenow (D-MI) and co-sponsors Sens. Tammy Baldwin (D-WI), Susan Collins (R-ME), Chris Coons (D-DE), and Al Franken (D-MN) for introducing the Renewable Chemicals Act of 2017 (S.1980), which would create a targeted, short…
BIO Investor Forum Concludes
October 18, 2017
The BIO Investor Forum finished today after hosting two days of expert-led panel discussions, fireside chats, over 165 company presentations and more than 2,750 individual meetings arranged through BIO One-on-One Partnering — a 26 percent increase…
Hill Leaders Urge Support for Reg System that Supports Ag Innovation
October 17, 2017
USDA, FDA and EPA must “coordinate with each other and stakeholders” Washington, D.C. (October 17, 2017) – Under the leadership of Reps. Neal Dunn (R-Fla.) and Jimmy Panetta (D-Calif.), 79 Members of the House of Representatives signed on to a…
BIO Statement on California Governor Brown Signing Drug Price Reporting & Transparency Bill
October 9, 2017
BIO will continue to oppose legislative efforts, such as SB 17, that harm patient access to needed care by undermining competition, disrupting existing drug product availability, or stifling investment in the innovation ecosystem through misguided…
BIO Congratulates SAB Biotherapeutics on Pharm Groundbreaking
October 5, 2017
Sioux Falls, S.D. 80-acre biological pharm is first-of-its kind Washington, D.C. (October 5, 2017) – Sioux Falls, S.D.-based SAB Biotherapeutics, Inc. (SAB), celebrated construction of their 80-acre biopharmaceutical production pharm operation…
Sixth Annual BIO Patient and Health Advocacy Summit Concludes Today
October 3, 2017
The 2017 Patient and Health Advocacy Summit wrapped up today, having offered the nearly 240 patient groups, companies and organizations new ways to connect, strategize, learn and partner.  For the past six years, the BIO Patient and…
BIO to Offer Complimentary Access to One-on-One Partnering™ During J.P. Morgan Healthcare Conference (“JPM Week”)
September 28, 2017
BIO will offer complimentary access to its proprietary BIO One-on-One Partnering™ during "JPM" week January 7-11, 2018 
BIO Statement on California’s Drug Price Reporting & Transparency Bill
September 13, 2017
California Senate Bill 17 is bad for patient and does not deliver on its purported promises
FDA Commissioner, Dr. Scott Gottlieb, to Address BIO Patient and Health Advocacy Summit
September 5, 2017
The head of the United States Food and Drug Administration, Dr. Scott Gottlieb, will be the keynote speaker at the BIO Patient and Health Advocacy Summit, October 2-3 at the Mayflower Hotel in Washington, DC. The annual event brings together…
PhRMA and BIO Initiate Litigation to Challenge Unconstitutional Provisions of Nevada’s SB 539
September 1, 2017
Washington, DC (September 1, 2017) – The Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization (BIO) today initiated litigation in the United States District Court for the District of Nevada…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today